• PSU23 Rehabilitation Needs and Predictive Factors of Health-Related Quality-of-Life in Breast Cancer Patients During Two Years After Surgery - A Multicenter Prospective Study

    Nov 1, 2011, 00:00

  • PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United States

    Nov 1, 2011, 00:00

  • PND9 The Role of Spontaneous Events Databases for Benefit-Risk Analysis

    Nov 1, 2011, 00:00

  • PHP108 Public Health and Prevention in Europe- Is it Cost-Effective?

    Nov 1, 2011, 00:00

  • PHP121 The Role of Molecular Tests in Shaping Comparative Effectiveness Review (CER)

    Nov 1, 2011, 00:00

  • PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK Setting

    Nov 1, 2011, 00:00

  • PND1 Estimating Net Health Benefits Of Intramuscular Interferon Beta-1A And Fingolimod In Treating Patients With Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PSS9 The Burden of Age-related Macular Degeneration in the Netherlands

    Nov 1, 2011, 00:00

  • PIN6 Clinical Outcomes Analysis Comparing Entecavir with Lamivudine Monotherapy and Lamivudine with “Tenofovir Add-on as Needed” Approach in the Treatment of Chronic Hepatitis B Infection in Turkey

    Nov 1, 2011, 00:00

  • PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)

    Nov 1, 2011, 00:00

  • PCN185 A Multi-Country Retrospective Study of Patient Characteristics and Treatment Patterns in Chronic Myeloid Leukemia

    Nov 1, 2011, 00:00

  • PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment - a Systematic Literature Review

    Nov 1, 2011, 00:00

  • PCN82 Cost-Effectiveness Analysis of Trastuzumab + Docetaxel Versus Docetaxel Alone in the Treatment of HER2+ Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PHP35 Perceptions, Knowledge and Gaps about HTA and Health Economics by the Braziian Market Stakeholders- Ispor Brazil Qualitative Research

    Nov 1, 2011, 00:00

  • PMS28 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporotic Fractures in Slovenia, Serbia and Bulgaria

    Nov 1, 2011, 00:00

  • PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

    Nov 1, 2011, 00:00

  • PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PRM38 Estimating SF-6D Health State Utility Values for Comorid Health Conditions

    Nov 1, 2011, 00:00

  • Copyright/Subscription

    Nov 1, 2011, 00:00

  • PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis- The Case of Epilepsy in France

    Nov 1, 2011, 00:00

  • PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy- A Chart Extraction-Based Approach

    Nov 1, 2011, 00:00

  • PMH64 Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia- A Three-Year Follow-up of Hypoglycemic Therapy

    Nov 1, 2011, 00:00

  • PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care- A Population-Based Intervention Study

    Nov 1, 2011, 00:00

  • PDB70 LOW-Dose Pioglitazone Utilisation in Patients with Type 2 Diabetes Mellitus in the United Kingdom

    Nov 1, 2011, 00:00

  • PND21 Cost of Alzheimer'S Disease in Romania

    Nov 1, 2011, 00:00

  • PSS45 Treatment Patterns, Treatment Satisfaction, Disease Severity and Quality of Life in Patients with Psoriasis in Denmark, Finland, and Sweden

    Nov 1, 2011, 00:00

  • PRS68 A Systematic Review of Chronic Rhinosinusitis in Asia-Pacfic and the Role of Balloon Sinuplasty

    Nov 1, 2011, 00:00

  • PCN156 A Survey Examining Treatment Patterns of Melanoma in Australia

    Nov 1, 2011, 00:00

  • MT1 Impact of the Choice of Prior Distribution on relative Effect Sizes Using Bayesian Network Meta-Analysis

    Nov 1, 2011, 00:00

  • PMS17 The Effect of Biological Treatment on Work Productivity and Productivity Costs of Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PSS17 Societal Burden of Blindness in Hungary

    Nov 1, 2011, 00:00

  • HS1 Interchangeability Between Pneumococcal Conjugate Vaccines and Schemes

    Nov 1, 2011, 00:00

  • PIH17 Burden of Illness in Patients with Neural Tube Defects in Germany

    Nov 1, 2011, 00:00

  • PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B Patients

    Nov 1, 2011, 00:00

  • PSY9 Evaluación Económica De Dieta Inmunoreguladora (Inmunex Plus®) En Pacientes Mexicanos

    Nov 1, 2011, 00:00

  • PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study)- French Results

    Nov 1, 2011, 00:00

  • PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program- Analysis Versus Canada and Australia

    Nov 1, 2011, 00:00

  • PIN28 Consumption Pattern and the Cost Analysis of Parenteral Antibiotics in A

    Nov 1, 2011, 00:00

  • PDB83 The Epidemiology and Burden of Obesity and Diabetes in Fran A Methodological Comparison

    Nov 1, 2011, 00:00

  • PIH25 Cost-Effectiveness of Interventions Against Childhood Obesity

    Nov 1, 2011, 00:00

  • PMH22 Economic Burden of Attention Deficit Hyperactivity Disorder in Children and Adolescents in Europe

    Nov 1, 2011, 00:00

  • PCN84 Population Vaccination Program for Human Papillomavirus in Spanish Girls- An Efficiency Study

    Nov 1, 2011, 00:00

  • PDB68 The Impact of Implementing a Drug Preauthorization Policy in a Primary Care Setting

    Nov 1, 2011, 00:00

  • PIN15 Trends in Varicella-Zoster Incidence in the Netherlands Boosting Effect Within Households

    Nov 1, 2011, 00:00

  • PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based Study

    Nov 1, 2011, 00:00

  • PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy- A German Statutory Health Insurance Perspective

    Nov 1, 2011, 00:00

  • PCN54 Hospital Costs Related to Hepatitis C Virus Infection- First Analysis of the French Hospital National Data Base

    Nov 1, 2011, 00:00

  • PC2 Estimation of Productivity Costs Using the Friction Cost Method- New Evidence Using National Data

    Nov 1, 2011, 00:00

  • PIN80 Cost-Effectiveness of Vaccinating Children Aged 2-17 Years with Intranasal Live Attenuated Influenza Vaccine (LAIV) in Germany

    Nov 1, 2011, 00:00

  • PND18 Recent Trends in Muscular Dystrophy-Related Inpatient Care Among Pediatric Patients In The United States

    Nov 1, 2011, 00:00

  • PDB48 SHORT-Term Cost-Effectiveness of Insulin Detemir Versus NPH Insulin in Insulin-Naïve Subjects with Type 2 Diabetes in Sweden

    Nov 1, 2011, 00:00

  • PCN145 Measurement Properties of the English and Chinese Versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PHP40 Perception Study of Undergraduates Towards Medicines – A Survey

    Nov 1, 2011, 00:00

  • PIN74 A Cost-Effectiveness Analysis of Vaccinating the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Germany

    Nov 1, 2011, 00:00

  • PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in Bulgaria

    Nov 1, 2011, 00:00

  • PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia- Using Outpatient Data from the REACH Registry

    Nov 1, 2011, 00:00

  • PCV67 Health-Economic Impact of the Hungarian Salt Intake Reduction Program

    Nov 1, 2011, 00:00

  • PIN34 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Vaccination of Dutch Elderly

    Nov 1, 2011, 00:00

  • PRS25 Systematic Literature Review of Economic and Humanistic Burden of Dyspnoea in COPD

    Nov 1, 2011, 00:00

  • PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic Agents

    Nov 1, 2011, 00:00

  • PMD61 The Effects of Subjective Insomnia Pattern on the quality of Life of the Climacteric Women in Taiwan

    Nov 1, 2011, 00:00

  • PMS69 Effectiveness the Treatments with Natural Mineral Water in Low Back Pain for Spondylarthrosis

    Nov 1, 2011, 00:00

  • PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pi ...

    Nov 1, 2011, 00:00

  • PRM25 Switch of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- The Development of a Flexible and Generic European Budget Impact Model

    Nov 1, 2011, 00:00

  • PDB4 Gastos Com Medicamentos E Características De indivÍduos Com HipertensÃo E Diabetes Mellitus, Em MunicÍpios Da rede FarmÁcia De Minas - Minas Gerais, Brasil

    Nov 1, 2011, 00:00

  • PDB79 Application of the Subgroup Identification Tool Using a Health Care Database- Treatment Response Heterogeneity in Type II Diabetes

    Nov 1, 2011, 00:00

  • PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia

    Nov 1, 2011, 00:00

  • PRS13 Specific Immunotherapy and the Economic Implications from the Perspective of German Statutory Health Insurance - a Budget-Impact Modeling Approach

    Nov 1, 2011, 00:00

  • PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United States

    Nov 1, 2011, 00:00

  • VA4 Costo-Efectividad De La Vacuna Contra El Vph Subtipos 16 Y 18 En México

    Nov 1, 2011, 00:00

  • PMD12 Economic Impact analysis of Sterilization of Rigid Endoscopes with Sterradtm versus Steam in Spain

    Nov 1, 2011, 00:00

  • PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil- Cost analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PR4 Calidad De Vida Y Victimizacion En Adolescentes Estudiantes De MÉxico

    Nov 1, 2011, 00:00

  • PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

    Nov 1, 2011, 00:00

  • PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En México

    Nov 1, 2011, 00:00

  • PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PCV8 Effect of SIADH on Patient Outcomes and Health Care Resource Utilization in Hospitalized Patients

    Nov 1, 2011, 00:00

  • PRM17 Suitability of CLAD-CQR Models for Obtaining QALYs

    Nov 1, 2011, 00:00

  • PHP16 Waiting Time and Its Implications on the Utilization of Antenatal Services in A Free Service Provision Setting in the Asante Akim North Municipal, Ghana

    Nov 1, 2011, 00:00

  • PIH14 Rates and Predictors of Chlamydia re-Screening among Privately insured Patients with Chlamydia in 2007- 2009

    Nov 1, 2011, 00:00

  • PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada

    Nov 1, 2011, 00:00

  • PHP32 Lineamientos De Una PolÍtica De investigación En Salud En Chile- Acuerdos De La Comisión Técnica De investigación Sanitaria Para El Plan Nacional De Salud 2011-2020

    Nov 1, 2011, 00:00

  • PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial

    Nov 1, 2011, 00:00

  • HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion Mexicana

    Nov 1, 2011, 00:00

  • PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations

    Nov 1, 2011, 00:00

  • PIH16 analyzing the Adverse Drug reactions of Geriatric Population at A regional Academic Hospital of southern Taiwan

    Nov 1, 2011, 00:00

  • PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies

    Nov 1, 2011, 00:00

  • PMH18 The Economic and Social Consequences of Seroquel XR® (Quetiapine Prolonged Release Tablets) Reimbursement in Bipolar Disorder Treatment for Patients Currently Treated with Seroquel (Quetiapine Immediate Release Tablets) in Poland- Ana ...

    Nov 1, 2011, 00:00

  • PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure- The International PGRX Database Experience

    Nov 1, 2011, 00:00

  • PHP11 Fact or Fallacy- Does Medical Technology Drive Health Care Spending?

    Nov 1, 2011, 00:00

  • PIN104 Pro's in Evaluating Resource Utilisation and Absenteeism in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PMS57 Preliminary Psychometric Validation of the Sleep Disturbance and Sleep Adequacy Subscales of the 1-Week Recall Medical outcomes Study Sleep Scale in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

    Nov 1, 2011, 00:00

  • PSU6 Long Term Effectiveness of Limbal Relaxing Incision (LRI) During Cataract Surgery to Correct Astigmatism

    Nov 1, 2011, 00:00

  • PMS53 Work Productivity and Productivity Costs of Patients with Ankylosing Spondylitis in the Czech Republic

    Nov 1, 2011, 00:00

  • PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov Model

    Nov 1, 2011, 00:00

  • PCV69 Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension- A Scenario Analysis for the Netherlands

    Nov 1, 2011, 00:00

  • PCN163 Funding by SHAs for Rarer Cancers in England- Key Success Factors in the Uptake of Cancer Drugs Fund

    Nov 1, 2011, 00:00

  • PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in Development

    Nov 1, 2011, 00:00

  • PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics- The Case of Orphan Indications

    Nov 1, 2011, 00:00

  • PSY30 Cost Effectiveness of Tramadol Versus Diclophenac in Pain Management After Cesarean Delivery

    Nov 1, 2011, 00:00

  • PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia

    Nov 1, 2011, 00:00

  • PCN120 The Natural History of Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients Who Fail Alemtuzumab or Have Bulky Lymphadenopathy – A European Perspective

    Nov 1, 2011, 00:00

  • PIN10 Clinical and Economic Burden of Hospital Onset Health Care Facility Acquired Clostridium Difficile Infection (HO-HCFA-CDI) in Europe- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PIH44 Health-Related Quality of Life for Patients with Chronic Conditions- Revealing the Profile of Burden Associated with Co-Morbid Physical and Mental Conditions in Respondents from Five European Countries

    Nov 1, 2011, 00:00

  • PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in Dystonia

    Nov 1, 2011, 00:00

  • PSY40 Eq-5D Utilities in Patients with Chronic Pain Due to Osteoarthritis of the Knee or Low Back Pain Treated with Tapentadol and Oxycodone

    Nov 1, 2011, 00:00

  • PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

    Nov 1, 2011, 00:00

  • PSS46 Availability of Resources for Patients With Wet Age-Related Macular Degeneration- Optimal Study

    Nov 1, 2011, 00:00

  • PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2011, 00:00

  • PHP34 Necesidades De información Y formación Sobre Farmacoeconomia E Investigación De Resultados Para Profesionales Y Estudiantes De Farmacia Del Oriente Venezolano

    Nov 1, 2011, 00:00

  • PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes Patients

    Nov 1, 2011, 00:00

  • PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?

    Nov 1, 2011, 00:00

  • PSS4 Longer Term Patient Benefits of Polyquad® Preservative Instead of Benzalkonium Chloride in Prostaglandin Eye Drops- A Microsimulation Model in Ocular Hypertension and Open-Angle Glaucoma

    Nov 1, 2011, 00:00

  • PHP133 Levels of Population Risk Stratification Based on the Cost of Care in Patients with Chronic Diseases

    Nov 1, 2011, 00:00

  • PHP11 The Use of Methylphenidate in A Group of Patients with Attention Deficit and Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PCV26 Real World Add-On and Switch Patterns for Platelet Aggregation Inhibitors

    Nov 1, 2011, 00:00

  • PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

    Nov 1, 2011, 00:00

  • PCN170 Direct Costs of Head and Neck Cancer in the US- An Analysis Using 2008 Medical Expenditure Panel Survey (MEPS) Data

    Nov 1, 2011, 00:00

  • PCN155 The Challenges of Estimating Costs of Palliative Care- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PIH9 Follow Up Balance and Gait Examination During Pregnancy

    Nov 1, 2011, 00:00

  • PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile Neutropaenia

    Nov 1, 2011, 00:00

  • PND60 An Examination of Medication Treatment Patterns Among Patients with Parksinson'S Disease Who Utilize Rasagiline or Selegiline

    Nov 1, 2011, 00:00

  • PCN192 BIA Results Could Stop Introduction of Cost-Effectiveness Therapy into Standard Treatment - Example from Croatia

    Nov 1, 2011, 00:00

  • PIH6 Treatment Patterns and Associated Clinical and Economic Outcomes of Women Treated with Hormone Therapy

    Nov 1, 2011, 00:00

  • PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice

    Nov 1, 2011, 00:00

  • PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer

    Nov 1, 2011, 00:00

  • PSY9 A Budget Impact Model of Rituximab Introduction in Wegener Granulomatosis Therapies

    Nov 1, 2011, 00:00

  • PMD24 Cost-Effetiveness of 3M ™ Coban 2 ™ Compression System in the Treatment of Lymphoedema

    Nov 1, 2011, 00:00

  • PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder Symptoms

    Nov 1, 2011, 00:00

  • PCV144 Stroke Prevention in Patients with Atrial Fibrillation- Inappropriate Anticoagulation and Poor INR Control

    Nov 1, 2011, 00:00

  • PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research

    Nov 1, 2011, 00:00

  • PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in Greece

    Nov 1, 2011, 00:00

  • PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria

    Nov 1, 2011, 00:00

  • PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver Toxicity

    Nov 1, 2011, 00:00

  • PMS11 Establishing the Safety of Tumour Necrosis Factor Inhibition (TNF-I) in Rheumatoid Arthritis (RA) from an Analysis of Real World Data

    Nov 1, 2011, 00:00

  • PND5 Efficacy and Safety of Immuno-regulatory Drugs, Interferons Beta and Glatiramer in Relapsing – Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in Malaysia

    Nov 1, 2011, 00:00

  • PHP100 Did Iqwig‘S Drug Appraisals in Connection with G-BA‘S Directives Change Prescribing Behavior of German Physicians?

    Nov 1, 2011, 00:00

  • PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy

    Nov 1, 2011, 00:00

  • PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement Solution

    Nov 1, 2011, 00:00

  • PMH46 The Quality of Life of Children With ADHD and their Parents- Results of EQ-5D and Kidscreen-10

    Nov 1, 2011, 00:00

  • PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in Germany

    Nov 1, 2011, 00:00

  • PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?

    Nov 1, 2011, 00:00

  • PMH70 Economic Impact of Focal Epilepsy in Spain- Results of the Espera Study

    Nov 1, 2011, 00:00

  • PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b- A Cost-Effectiveness Analysis for the Portuguese NHS Setting

    Nov 1, 2011, 00:00

  • PIH22 Cost Effectiveness of an infant Pneumococcal Conjugate Vaccine program in China

    Nov 1, 2011, 00:00

  • PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal

    Nov 1, 2011, 00:00

  • PRM11 Learning Effect in Economic Evaluations of Health Care Interventions

    Nov 1, 2011, 00:00

  • PRS58 Treatment Outcomes of New Smear Positive Pulmonary Tuberculosis Patients in North East Libya

    Nov 1, 2011, 00:00

  • PCN175 Reimbursement of Anticancer Drugs in Canada- What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?

    Nov 1, 2011, 00:00

  • PSS15 Burden of Chronic Tinnitus in Hungary

    Nov 1, 2011, 00:00

  • PDB59 Nocturnal Hypoglycemic Events- Impacts on Patients Functioing, Well-Being and Diabetes Management

    Nov 1, 2011, 00:00

  • PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PMD65 Systematic Review of Studies of the Efficiency of Negative Pressure therapy for Complex Foot Wounds in Diabetic Patients

    Nov 1, 2011, 00:00

  • PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care- Comparing Infliximab to Methotrexate and Systemic Steroids

    Nov 1, 2011, 00:00

  • PCV1 Costs, Length of Stay and ALL-Cause Mortality in Ruptured Versus Unruptured Cerebral Aneurysm Among Inpatients in the United States

    Nov 1, 2011, 00:00

  • PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain

    Nov 1, 2011, 00:00

  • PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic Review

    Nov 1, 2011, 00:00

  • PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United States

    Nov 1, 2011, 00:00

  • PSU25 Effectiveness of Minimally Invasive Surgery for Total Hip Arthroplasty

    Nov 1, 2011, 00:00

  • PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents

    Nov 1, 2011, 00:00

  • PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care Plan

    Nov 1, 2011, 00:00

  • PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in Spain

    Nov 1, 2011, 00:00

  • PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With Psoriasis

    Nov 1, 2011, 00:00

  • PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European Countries

    Nov 1, 2011, 00:00

  • PIH62 Comparative Pricing and Reimbursement Analysis in Four East European Countries

    Nov 1, 2011, 00:00

  • PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

    Nov 1, 2011, 00:00

  • PDB9 Weight Loss, Independent of Drug Class, Predicts HbA1c Goal Attainment in Patients 65 Years and Older in a Real-World Setting

    Nov 1, 2011, 00:00

  • MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer Patients

    Nov 1, 2011, 00:00

  • PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland

    Nov 1, 2011, 00:00

  • PCV141 Current Management Pathway of Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece. Results from Aptorii Study

    Nov 1, 2011, 00:00

  • PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease- Cost-Effectiveness in the Dutch Population

    Nov 1, 2011, 00:00

  • PHP50 Irrational Use of Injectable Form of Dexamethasone- A Warning for Health System in Iran

    Nov 1, 2011, 00:00

  • PRM10 to Get the Right Price – A Decision Support Method to Optimize Managerial Decisions on Public Funding Price to Apply for

    Nov 1, 2011, 00:00

  • PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and Belgium

    Nov 1, 2011, 00:00

  • PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients- An Analysis with the RAMQ Database

    Nov 1, 2011, 00:00

  • PND30 Cost-Effectiveness of Early vs. Non-Early Intervention in Acute Migraine with Almotriptan in Spain

    Nov 1, 2011, 00:00

  • PSS7 Prevalence Assessment of Diabetic Macular Edema With Visual Impairment in Spain- A Prevail Study

    Nov 1, 2011, 00:00

  • PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption

    Nov 1, 2011, 00:00

  • PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America- Un Estudio Comparativo

    Nov 1, 2011, 00:00

  • PCV99 Utilisation of Renin –Angiotensin System Agents Involved in Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2011, 00:00

  • PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS)- A Dutch Analysis Based on the Plato Trial

    Nov 1, 2011, 00:00

  • PDB44 An Economic Evaluation of the Use of Pioglitazone in Italy Using Proactive

    Nov 1, 2011, 00:00

  • PCN174 Variations in Drug Administration Costs for Stage III/IV NSCLC in Europe

    Nov 1, 2011, 00:00

  • CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion Medica

    Nov 1, 2011, 00:00

  • PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA

    Nov 1, 2011, 00:00

  • PHP7 Impact of Global Health Care Reforms on Pricing, Access and Health Economics and outcomes Strategy

    Nov 1, 2011, 00:00

  • PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials- Evaluation of Structual Equation Modelling for Assessing Equivalence

    Nov 1, 2011, 00:00

  • PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue- a Mathematical Simulation Study for the German Population

    Nov 1, 2011, 00:00

  • PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting

    Nov 1, 2011, 00:00

  • PHP76 The Lack of BIA Methodology in the Czech Republic Leads to Inappropriate Public Health Insurance Budgeting

    Nov 1, 2011, 00:00

  • PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?

    Nov 1, 2011, 00:00

  • PDB65 Unmet Need and Drug Management Challeneges in Elderly Type 2 Diabetes Medicare Part D Population

    Nov 1, 2011, 00:00

  • PMD66 Demand for Routine in office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PSY52 Impact of Two Different Treatment Approaches on Epidemiology of inhibitor Hemophilia in Russia

    Nov 1, 2011, 00:00

  • PCN41 Hospital Health Care Costs for the Management of HER2-Positive Breast Cancer with Brain Metastases

    Nov 1, 2011, 00:00

  • PCV116 The Impact of High Risk of Stroke Patients Diagnosed with atrial Fibrillation on Health-Related Quality of Life, and Health Care Use in 5EU

    Nov 1, 2011, 00:00

  • PND4 El Impacto Economico Del Tabaquismo En El Desarrollo De La Enfermedad Vascular Cerebral En Un Centro Neurologico De Tercer Nivel

    Nov 1, 2011, 00:00

  • PRS74 Measurement Of A Possible Patch Testing Outcome Indicator

    Nov 1, 2011, 00:00

  • PGI32 An Investigation into the Extensive Spectrum of Agents Used for the Management of Post-Operative Ileus

    Nov 1, 2011, 00:00

  • PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

    Nov 1, 2011, 00:00

  • PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In Argentina

    Nov 1, 2011, 00:00

  • PMS50 Cost-Effectiveness of Biologic Agents Compared with Methotrexate in the Treatment of Rheumatoid Arthritis in Colombia

    Nov 1, 2011, 00:00

  • PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies

    Nov 1, 2011, 00:00

  • PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection ...

    Nov 1, 2011, 00:00

  • PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Panama

    Nov 1, 2011, 00:00

  • PCV23 Clopidodgrel and Statin Prescribing Patterns in ACS Patients – an Observational Study Using Linked Secondary and Primary Care Data in a UK Population 2003-2009

    Nov 1, 2011, 00:00

  • PCN124 The Impact of Condition Labelling on Health State Values

    Nov 1, 2011, 00:00

  • HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in Belize

    Nov 1, 2011, 00:00

  • PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association- How Much Does Cost-Effective Treatment Cost?

    Nov 1, 2011, 00:00

  • PHP159 Structures for the Role of Health Technology Assessment in Translational Research

    Nov 1, 2011, 00:00

  • PRM47 Review of Clinician and Observer Reported Outcomes Measures Translation Methodologies

    Nov 1, 2011, 00:00

  • PMH75 Physician Differences between Italy and Germany- The Treatment of Opioid Dependence with Substitution Therapy

    Nov 1, 2011, 00:00

  • VI2 A Novel Approach to analysing Value Driver Importance Across Multiple Target Product Profiles

    Nov 1, 2011, 00:00

  • PCN2 Cost-Effectiveness and Budget Impact Analysis of an Immediate Care Center at the National Cancer Institute, Mexico

    Nov 1, 2011, 00:00

  • PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?

    Nov 1, 2011, 00:00

  • PDB53 Diabetes Medication Adherence and Glycemic Control in Penang, Malaysia

    Nov 1, 2011, 00:00

  • PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries- Results from the Lupus European Online (Leo) Survey

    Nov 1, 2011, 00:00

  • PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain

    Nov 1, 2011, 00:00

  • PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and Adenoidectomy

    Nov 1, 2011, 00:00

  • PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in Mexico

    Nov 1, 2011, 00:00

  • PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients with Chemotherapy Induced Anemia (CIA) in Greece

    Nov 1, 2011, 00:00

  • IN3 Dengue MÁs Que Un Problema De Salud PÚblica- EstimaciÓn De Los Costos Directos De La Epidemia Del AÑo 2010 En Colombia

    Nov 1, 2011, 00:00

  • PHP44 Characteristics of Patients Treated for Fibromyalgia in Puerto Rico and the United States- Baseline Findings of the Reflections Study (Real World Examination of Fibromyalgia- Longitudinal Evaluation of Costs and Treatments)

    Nov 1, 2011, 00:00

  • PSS25 the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Observation for the Treatment of Macular Oedema Following Central and Branch Retinal Vein Occlusion

    Nov 1, 2011, 00:00

  • PSU27 Fracture Related Treatments After Primary Surgical Interventions of Hip Fracture Eight Years Follow Up

    Nov 1, 2011, 00:00

  • PC1 The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Nov 1, 2011, 00:00

  • PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer Therapy

    Nov 1, 2011, 00:00

  • PMH25 Cost of Delivering Psychiatric Inpatient Care to Mental Health Patients with Psychosis and Co-Occuring Substance Use- A UK-Based Study

    Nov 1, 2011, 00:00

  • PUK6 BPH Patients Treated with Phytotherapy in Portugal- Results at Six Months

    Nov 1, 2011, 00:00

  • EX4 Efectividad De Los indicadores De Calidad De La Prescripción Regionales En El Sns Español

    Nov 1, 2011, 00:00

  • PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation Drugs

    Nov 1, 2011, 00:00

  • PHP37 Cross-Continental Comparison of HTA Evolution in Emerging Markets- Brazil, India and Poland

    Nov 1, 2011, 00:00

  • PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

    Nov 1, 2011, 00:00

  • PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients

    Nov 1, 2011, 00:00

  • QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in México

    Nov 1, 2011, 00:00

  • PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in Italy

    Nov 1, 2011, 00:00

  • PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Colombia

    Nov 1, 2011, 00:00

  • PCV62 Influence of Smoking on the Use of Health-Care resources and Costs in Patients with Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering Regimens

    Nov 1, 2011, 00:00

  • PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)

    Nov 1, 2011, 00:00

  • PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011

    Nov 1, 2011, 00:00

  • PRM53 Comparing Multiple Propensity Score Adjustment and Traditional Regression Analysis to Assess the Exposure-Outcome Association Using Retrospective Claims Data

    Nov 1, 2011, 00:00

  • PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia- Evidence from the Catie Study

    Nov 1, 2011, 00:00

  • PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Gree A Cost –Effectiveness Analysis under the Greek NHS Setting

    Nov 1, 2011, 00:00

  • PDB43 The Economic Impact of Weight Loss in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

    Nov 1, 2011, 00:00

  • PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults- A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R ...

    Nov 1, 2011, 00:00

  • PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients

    Nov 1, 2011, 00:00

  • PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany

    Nov 1, 2011, 00:00

  • PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study

    Nov 1, 2011, 00:00

  • PCV56 the Economic Burden of Atherothrombosis in Gree Results from the Thesis Study

    Nov 1, 2011, 00:00

  • PHP34 Pricing Insights Across Therapy Areas and European Countries - A Discussion of International Price References and Implications for Parallel Trade and Prescription Patterns of Pharmaceutical Products

    Nov 1, 2011, 00:00

  • HT3 Understanding the Complexity of HTA Networks

    Nov 1, 2011, 00:00

  • PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in Mexico

    Nov 1, 2011, 00:00

  • PHP95 Payer Perspectives on Evidence for Formulary Decision Making in the United States

    Nov 1, 2011, 00:00

  • PSY13 Efecto de un Programa de Atención Farmacéutica Para Pacientes Con Sobrepeso Y Obesos

    Nov 1, 2011, 00:00

  • PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary Disease

    Nov 1, 2011, 00:00

  • PMD70 A Review of the Geographic Variations in the Implant Rate of Transcatheter Aortic Valves in 14 European Countries

    Nov 1, 2011, 00:00

  • PSU11 Medico-Economic Analysis of the Impact of Malnutrition on the Post-Operative Course of Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PDB18 Australia- Management of the Diabetic Foot with Pedimed® Under Real Use Conditions

    Nov 1, 2011, 00:00

  • PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP82 A Study Explorating the General Public Perceptions Towards Medicines

    Nov 1, 2011, 00:00

  • PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury Patients

    Nov 1, 2011, 00:00

  • PGI20 Pharmacoeconomic Study of Glutamine Dipeptide Usage During Total Parenteral Nutrition (TPN)

    Nov 1, 2011, 00:00

  • PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France

    Nov 1, 2011, 00:00

  • PIH34 Patient Reported Reasons for Medication Nonadheren A Survey

    Nov 1, 2011, 00:00

  • PRM46 Linguistic Validation and ePRO – Value of Collaboration

    Nov 1, 2011, 00:00

  • PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain Tumors

    Nov 1, 2011, 00:00

  • PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals

    Nov 1, 2011, 00:00

  • PCN196 Review of Cost Effectiveness of Trastuzumab in Early Breast Cancer

    Nov 1, 2011, 00:00

  • PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic Disease

    Nov 1, 2011, 00:00

  • PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece

    Nov 1, 2011, 00:00

  • PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2011, 00:00

  • PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil- Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticos

    Nov 1, 2011, 00:00

  • PCN123 A Literature Review on Utility Values Associated With HPV-Related Diseases

    Nov 1, 2011, 00:00

  • PDB8 Cost-Effectiveness Study of Oral Hypoglycemic Agents in Outpatients Diagnosed with Type-2 Diabetes Attending a Primary Care Public Clinic in Mexico City

    Nov 1, 2011, 00:00

  • PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?

    Nov 1, 2011, 00:00

  • PMH27 An Economic Analysis of the Impact of Crime and Hospitalisation Associated with Different Interventions for Opioid Abuse in the United Kingdom

    Nov 1, 2011, 00:00

  • PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries

    Nov 1, 2011, 00:00

  • PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PRM56 Differential Discounting- Questioning the Assumption of Healthcare Resource Fungibility Over Time

    Nov 1, 2011, 00:00

  • CN1 Cost-Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PND23 Cost of the Informal Care of Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis

    Nov 1, 2011, 00:00

  • PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study- Excess Burden Due to Relapses

    Nov 1, 2011, 00:00

  • PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis- Final 24-Month Results From An Internationa ...

    Nov 1, 2011, 00:00

  • PND62 What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer'S Disease Treatment in Germany, France and UK

    Nov 1, 2011, 00:00

  • PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on Mortality

    Nov 1, 2011, 00:00

  • PDB72 The Burden of Hypoglycaemia in Secondary Care in England

    Nov 1, 2011, 00:00

  • PSY11 Budget Impact Model of Hemophilia a Treatment in Turkey- a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PRM43 Direct from the Patients – Research Into What Patients Would Like to Improve in Their Electronic Diary Experience

    Nov 1, 2011, 00:00

  • PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent Patients

    Nov 1, 2011, 00:00

  • PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PMH84 The Cornell-Brown Scale for Quality of Life in Dementia- Spanish Adaptation and Validation

    Nov 1, 2011, 00:00

  • PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland

    Nov 1, 2011, 00:00

  • PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland

    Nov 1, 2011, 00:00

  • PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece

    Nov 1, 2011, 00:00

  • PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in Pakistan

    Nov 1, 2011, 00:00

  • PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United Kingdom

    Nov 1, 2011, 00:00

  • PMS67 Determining the True Impact of Dupuytren'S Disease- A Qualitative Study

    Nov 1, 2011, 00:00

  • PMS78 Measurement Strategy for Kyphosis- New Evidence from Patients and Physicians

    Nov 1, 2011, 00:00

  • PCV103 Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database

    Nov 1, 2011, 00:00

  • PCV143 Implementation of Evidence-Based National Guidance on Venous Thrombo-Embolism Prophylaxis for Hospital Inpatients in England

    Nov 1, 2011, 00:00

  • PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients- A Within Trial Analysis from the Perspective of the ...

    Nov 1, 2011, 00:00

  • PIN101 New Insights on the Spread of Influenza Through Agent Based Epidemic Modeling

    Nov 1, 2011, 00:00

  • PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary Statistics

    Nov 1, 2011, 00:00

  • PCN176 Cancer Drug Prices in the United States and the United Kingdom- Implications for Pricing Strategy and Drug Access

    Nov 1, 2011, 00:00

  • PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along Spain

    Nov 1, 2011, 00:00

  • PSU22 Performance of the Functional Assessment of Visual Tasks (VISTAS-18) among Cataract Patients Receiving Monofocal and Multifocal Intraocular Lens Implants

    Nov 1, 2011, 00:00

  • EX3 Incremental Cost of Implementing A Care Program for People with Type 2 Diabetes in Argentina

    Nov 1, 2011, 00:00

  • PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) Database

    Nov 1, 2011, 00:00

  • PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)

    Nov 1, 2011, 00:00

  • PMS13 The Burden of Juvenile Idiopatic Arthritis (JIA) in Russia- A Retrospective Review of Direct and Indirect Costs

    Nov 1, 2011, 00:00

  • PIN113 A New Framework for Understanding the Impact of Hepatitis C and Its Treatment on Quality of Life

    Nov 1, 2011, 00:00

  • PCN157 The Impact of a Patient Support Program on Access to Oral Oncology Therapy in the United States

    Nov 1, 2011, 00:00

  • PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

    Nov 1, 2011, 00:00

  • PHP26 A SatisfaÇÃo Dos Profissionais De SaÚde vs A SatisfaÇÃo Dos Utentes Em Unidades De Cuidados Continuados

    Nov 1, 2011, 00:00

  • PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial

    Nov 1, 2011, 00:00

  • PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines

    Nov 1, 2011, 00:00

  • PMD32 Cost Effectiveness of Cervical Cancer Screening in Serbia- A Comparison of Screening Policies

    Nov 1, 2011, 00:00

  • PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy

    Nov 1, 2011, 00:00

  • PCV78 A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin in Patients with Atherothrombosis in Greece

    Nov 1, 2011, 00:00

  • PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in Greece

    Nov 1, 2011, 00:00

  • PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR Delegates

    Nov 1, 2011, 00:00

  • PMD74 Home Dialysis Modalities- The Development of A Framework to Identify and Quantify Favourable Renal Policy and Reimbursement Factors

    Nov 1, 2011, 00:00

  • PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PRM3 Challenges to Obtain Real-Life Data in Observational Studies- What are the Solutions When the Patient is the Main Data Provider?

    Nov 1, 2011, 00:00

  • PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry)- A “Real Life” Overview of Treatment by Office-Based Oncologists in Germany

    Nov 1, 2011, 00:00

  • PIH63 The KIGS Quality Insight Program Assessing the Quality of Care for Short Children Treated with Growth Hormone Using the Output from a Large Pharmaco-Epidemiological Survey

    Nov 1, 2011, 00:00

  • PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care Population

    Nov 1, 2011, 00:00

  • PCV35 Safety and Tolerability of Bisoprolol Compared to Atenolol in Patients with Mild to Moderate Hypertension

    Nov 1, 2011, 00:00

  • PC4 Health Services Utilization, Work absenteeism and Costs of Pandemic influenza A (H1N1)

    Nov 1, 2011, 00:00

  • PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine- The Belgian Case

    Nov 1, 2011, 00:00

  • PRS76 Systematic Literature Review of Conceptual Models to Inform Economic Modelling in COPD

    Nov 1, 2011, 00:00

  • PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”

    Nov 1, 2011, 00:00

  • PCN17 Correlations Between Surrogate End Points and overall Survival in Advanced or Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PMD35 Cost-Effectiveness Analysis of the Corail Hip System for Primary total Hip Arthroplasty in Spain

    Nov 1, 2011, 00:00

  • PRS48 Cost-Utility Analysis of Varenicline vs Existing Smoking Cessation Strategies in EL Salvador

    Nov 1, 2011, 00:00

  • PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer- A Review of the Literature

    Nov 1, 2011, 00:00

  • PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South Korea

    Nov 1, 2011, 00:00

  • PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland

    Nov 1, 2011, 00:00

  • PUK3 COST-Effectiveness Of Anemia Treatment In Dialysis Patients In BRAZIL

    Nov 1, 2011, 00:00

  • QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para Colombia

    Nov 1, 2011, 00:00

  • PIH15 Estimating Herpes Zoster Disease Burden in Germany

    Nov 1, 2011, 00:00

  • PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma- Patients and Caregivers in the Spanish Pediatric Population- A Prex Study

    Nov 1, 2011, 00:00

  • PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insurance

    Nov 1, 2011, 00:00

  • PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo

    Nov 1, 2011, 00:00

  • PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults- Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PMD55 Resource Utilisation related to Urinary Tract infections in Swedish Self-Catheterisation Patients

    Nov 1, 2011, 00:00

  • PND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PHP62 Establish Drugs Optimal Purchase Model

    Nov 1, 2011, 00:00

  • PHP155 Review of Cost Effectiveness Models of High Budget Impact Drugs

    Nov 1, 2011, 00:00

  • PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxico

    Nov 1, 2011, 00:00

  • PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

    Nov 1, 2011, 00:00

  • PR3 Industry Preparedness against German reforms

    Nov 1, 2011, 00:00

  • PCV61 are Hospital Costs for Stroke Underestimated in Spain?

    Nov 1, 2011, 00:00

  • PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

    Nov 1, 2011, 00:00

  • HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?

    Nov 1, 2011, 00:00

  • PCV57 Epidemiological Structure, Socioeconomic Effects and Burden of Disease in Patients with Oral Anticoagulation and Atrial Fibrillation in Austria

    Nov 1, 2011, 00:00

  • PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone – A Markov Model Parameterized Using Administrative Data

    Nov 1, 2011, 00:00

  • PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury- A Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PDB28 The Roleof Diabetes and Body Mass Index on Medical Expenses, an Analysis of the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela- Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)

    Nov 1, 2011, 00:00

  • PIN14 Prescribing Patterns of Sebivo® (Telbivudine)- A Survey Among Physicians in Selected European Countries

    Nov 1, 2011, 00:00

  • PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey

    Nov 1, 2011, 00:00

  • PND15 Economic Burden of Chronic Migraine in Taiwan

    Nov 1, 2011, 00:00

  • PIN98 Evaluating Optimal Treatment Outcomes of Antiviral Therapy in Hepatitis C for Prior Null Responders in the Era of First Generation Protease Inhibitors

    Nov 1, 2011, 00:00

  • PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish Adolescents

    Nov 1, 2011, 00:00

  • PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in Germany

    Nov 1, 2011, 00:00

  • PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...

    Nov 1, 2011, 00:00

  • PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009

    Nov 1, 2011, 00:00

  • PHP35 Is Value Based Pricing Executed In Real Life Situation? – Global Perspectives

    Nov 1, 2011, 00:00

  • PCV137 The Impact of Dementia on Care Patterns After Discharge for Acute Coronary Syndromes Under National Health Insurance System

    Nov 1, 2011, 00:00

  • PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Systematic Review

    Nov 1, 2011, 00:00

  • PCN31 Sequential Treatment of Metastatic Renal Cell Carcinoma with Targeted Therapies- Adverse Events Associated Costs, from the Public and Private Perspectives in Brazil

    Nov 1, 2011, 00:00

  • PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PRM37 Assessing the Health Status of Roma Population by Using SF-36 Health Survey- Evidence from Greece

    Nov 1, 2011, 00:00

  • PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PSU17 Cost-Effectiveness of DSAEK Versus PK for Corneal Endothelialdisease

    Nov 1, 2011, 00:00

  • PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting- A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic Evaluation

    Nov 1, 2011, 00:00

  • PCN130 Utility Weights for Skeletal Related Events in Castration Resistant Prostate Cancer

    Nov 1, 2011, 00:00

  • PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database Study

    Nov 1, 2011, 00:00

  • PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population- A Nice Diagnostic Guidance Project

    Nov 1, 2011, 00:00

  • PSU7 Implications of Alloarthroplastic Infections in Hip and Knee Surgery

    Nov 1, 2011, 00:00

  • PND47 The Huntington Clinical Self-Reported Instrument (H-CSRI)- Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands- How Much Practice Variation is There?

    Nov 1, 2011, 00:00

  • MT2 The Use of Continuous Data versus Categorical Data in MTC- The Case of HAQ Multiplier in Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP88 Societal Unmet Needs within Spain

    Nov 1, 2011, 00:00

  • PIH8 Impact Assessment of Sport- Recreation Training

    Nov 1, 2011, 00:00

  • PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time

    Nov 1, 2011, 00:00

  • PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PRM59 Estimating the Confidence Interval for the Cost-Effectiveness Ratio from A Family of Regressions on Net Monetary Benefit

    Nov 1, 2011, 00:00

  • PCV90 Development of an Institutional Cost of Care Model for Anticoagulation Management of Patients with Warfarin Versus Novel Oral Agents

    Nov 1, 2011, 00:00
  • «
  • 131
  • 132
  • 133
  • 134 (current)
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »